Rapčan, Borna http://orcid.org/0009-0000-7265-5581
Song, Manshu http://orcid.org/0000-0003-1433-7192
Frkatović-Hodžić, Azra http://orcid.org/0000-0002-0751-4421
Pribić, Tea http://orcid.org/0000-0002-1071-8759
Vuk, Jakov http://orcid.org/0009-0009-3194-5027
Beletić, Anđelo http://orcid.org/0000-0001-8975-9600
Hanić, Maja http://orcid.org/0000-0001-6152-2054
Jurić, Julija http://orcid.org/0000-0002-1336-0772
Tominac, Petra
Milas, Josip http://orcid.org/0000-0001-6722-9289
Ivić, Vedrana http://orcid.org/0000-0002-8185-1960
Viland, Sven http://orcid.org/0009-0007-6087-9554
Bonet, Sara http://orcid.org/0009-0006-1686-5318
Šego, Branko http://orcid.org/0009-0005-0680-934X
Heffer, Marija http://orcid.org/0000-0001-6770-7359
Wang, Wei http://orcid.org/0000-0002-1430-1360
Snyder, Michael P. http://orcid.org/0000-0003-0784-7987
Lauc, Gordan http://orcid.org/0000-0003-1840-9560
Funding for this research was provided by:
Australia-China International Collaborative Grant (NHMRC APP1112767-NSFC 81561128020)
National Natural Science Foundation of China (NFSC 81773527, 81573215)
SynHealth (101159018)
Article History
Received: 3 April 2024
Accepted: 5 June 2024
First Online: 14 June 2024
Declarations
:
: All participants provided informed consent for this study. The plasma pool use was approved by the ethical board of the Croatian Institute for Transfusion Medicine (protocol code 251–541-0616–1). The “AstraZeneca MFO” study was approved by the Committee of the School of Medicine at the University of Osijek (protocol code 2158–61-46–22-149). The menstrual cycle cohort was approved by the Ethics Committee of the Capital Medical University (CMU), Beijing, China (protocol code 2016SY106) and by the Ethics Committee of the School of Medicine at the University of Zagreb, Croatia (protocol code 380–59-10106–18-111/151). The longitudinal study on two individuals was approved by the Ethical Board of Genos Ltd. (protocol code U-2023–05-589). The study was performed according to the Helsinki Declarations.
: Gordan Lauc is the founder and CEO of Genos Ltd. Borna Rapčan, Azra Frkatović, Tea Pribić, Anđelo Beletić and Maja Hanić are employees of Genos Ltd. Julija Jurić is an employee of GlycanAge Ltd. The participation of all authors from the companies did not affect their objectivity and authenticity of the experimental results. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.